Krishna Institute of Medical Sciences (NSE:KIMS) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KIMS Krishna Institute of Medical Sciences Ltd NSE:KIMS
85 GF Score
Price ₹811.10
GF Value ₹843.61
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Krishna Institute of Medical Sciences Marketable Securities?

Krishna Institute of Medical Sciences NSE:KIMS +0.31% 85 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:KIMS with a GF Score™ of 85/100 and a GF Value™ of ₹843.61 (Fairly Valued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Krishna Institute of Medical Sciences's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Krishna Institute of Medical Sciences's annual Marketable Securities declined from Mar. 2024 (₹829 Mil) to Mar. 2025 (₹220 Mil) and declined from Mar. 2025 (₹220 Mil) to Mar. 2026 (₹151 Mil).

Krishna Institute of Medical Sciences  (NSE:KIMS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Krishna Institute of Medical Sciences Marketable Securities Related Terms

Krishna Institute of Medical Sciences Marketable Securities Historical Data

* Premium members only.

The historical data trend for Krishna Institute of Medical Sciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krishna Institute of Medical Sciences Marketable Securities Chart

Krishna Institute of Medical Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 1,643.54 726.47 829.00 220.00 151.00

Krishna Institute of Medical Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 937.00 0.00 151.00 0.00
NSE:KIMS
85GF Score
Krishna Institute of Medical Sciences Ltd NSE:KIMS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krishna Institute of Medical Sciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Krishna Institute of Medical Sciences and its competitors.
Is Krishna Institute of Medical Sciences' Marketable Securities too high?
Krishna Institute of Medical Sciences' current Marketable Securities is ₹0 Mil. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Marketable Securities compare to HCA and THC?
Krishna Institute of Medical Sciences' Marketable Securities of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Krishna Institute of Medical Sciences and its competitors. Krishna Institute of Medical Sciences's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹843.61, compared to a current price of ₹811.10 — trading 3.9% below its estimated fair value. The current Marketable Securities is ₹0 Mil. Krishna Institute of Medical Sciences' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued. The current stock price of ₹811.10 is trading 3.9% below its estimated GF Value™ of ₹843.61. GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.

Key valuation signals for NSE:KIMS:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹843.61 vs. price of ₹811.10 (3.9% below fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krishna Institute of Medical Sciences Business Description

Other Exchanges 543308:India
Address D. No. 1-8-31/1, Minister Road, Secunderabad, TG, IND, 500 003
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
85GF Score

Get the complete analysis for NSE:KIMS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹811.10
Price
₹843.61
GF Value